Literature DB >> 22779961

Convalescence advice following gynaecological surgery.

M Naidu1, A H Sultan, R Thakar.   

Abstract

This was a survey, undertaken in the UK, which was sent to all obstetricians and gynaecologists. The aim was to establish the current advice given for activities during convalescence after commonly performed benign gynaecological surgery. Questionnaires were sent to all the obstetricians and gynaecologists working in 235 NHS hospitals in the UK. The total response rate was 30.51%. There is substantial variability in the advice for activities during convalescence following gynaecological surgery. This has enormous implications - mainly financial. The economic impact of absence from work is enormous. One extra day of sick leave given to patients has a direct cost of approximately £34 million annually. Our survey highlights the need for structured and evidence-based recommendations for convalescence activities following benign gynaecological surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22779961     DOI: 10.3109/01443615.2012.693983

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  8 in total

1.  Process evaluation of a multidisciplinary care program for patients undergoing gynaecological surgery.

Authors:  E V A Bouwsma; A Vonk Noordegraaf; Z Szlávik; H A M Brölmann; M H Emanuel; J P Lips; W van Mechelen; A Mozes; A L Thurkow; J A F Huirne; J R Anema
Journal:  J Occup Rehabil       Date:  2014-09

2.  Cost-effectiveness of an internet-based perioperative care programme to enhance postoperative recovery in gynaecological patients: economic evaluation alongside a stepped-wedge cluster-randomised trial.

Authors:  Esther V A Bouwsma; Judith E Bosmans; Johanna M van Dongen; Hans A M Brölmann; Johannes R Anema; Judith A F Huirne
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

3.  Predictive factors of return to work after hysterectomy: a retrospective study.

Authors:  Suzanne J Dedden; Esther V A Bouwsma; Peggy M A J Geomini; Marlies Y Bongers; Judith A F Huirne
Journal:  BMC Surg       Date:  2022-03-04       Impact factor: 2.102

4.  The cost effectiveness of a tailored, web-based care program to enhance postoperative recovery in gynecologic patients in comparison with usual care: protocol of a stepped wedge cluster randomized controlled trial.

Authors:  Esther Va Bouwsma; Johannes R Anema; Antonie Vonk Noordegraaf; Dirk L Knol; Judith E Bosmans; Steven E Schraffordt Koops; Paul Jm van Kesteren; W Marchien van Baal; Jos P Lips; Mark H Emanuel; Petrus C Scholten; Alexander Mozes; Albert H Adriaanse; Hans Am Brölmann; Judith Af Huirne
Journal:  JMIR Res Protoc       Date:  2014-06-18

5.  Improving the provision of driving advice on discharge after abdominal surgery.

Authors:  Imogen Buss; Laura Gould
Journal:  BMJ Qual Improv Rep       Date:  2015-10-22

6.  A modified Delphi method toward multidisciplinary consensus on functional convalescence recommendations after abdominal surgery.

Authors:  Daphne C R van Vliet; Eva van der Meij; Esther V A Bouwsma; Antonie Vonk Noordegraaf; Baukje van den Heuvel; Wilhelmus J H J Meijerink; W Marchien van Baal; Judith A F Huirne; Johannes R Anema
Journal:  Surg Endosc       Date:  2016-05-02       Impact factor: 4.584

7.  Using patient data to optimize an expert-based guideline on convalescence recommendations after gynecological surgery: a prospective cohort study.

Authors:  Esther V A Bouwsma; Johannes R Anema; A Vonk Noordegraaf; Henrica C W de Vet; Judith A F Huirne
Journal:  BMC Surg       Date:  2017-12-06       Impact factor: 2.102

8.  Effectiveness of an internet-based perioperative care programme to enhance postoperative recovery in gynaecological patients: cluster controlled trial with randomised stepped-wedge implementation.

Authors:  Esther V A Bouwsma; Judith A F Huirne; Peter M van de Ven; Antonie Vonk Noordegraaf; Frederieke G Schaafsma; Steven E Schraffordt Koops; Paul J M van Kesteren; Hans A M Brölmann; Johannes R Anema
Journal:  BMJ Open       Date:  2018-01-30       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.